Page last updated: 2024-09-03

5-methoxy-6-methyl-2-aminoindan and amphetamine

5-methoxy-6-methyl-2-aminoindan has been researched along with amphetamine in 4 studies

Compound Research Comparison

Studies
(5-methoxy-6-methyl-2-aminoindan)
Trials
(5-methoxy-6-methyl-2-aminoindan)
Recent Studies (post-2010)
(5-methoxy-6-methyl-2-aminoindan)
Studies
(amphetamine)
Trials
(amphetamine)
Recent Studies (post-2010) (amphetamine)
130013,0713291,977

Protein Interaction Comparison

ProteinTaxonomy5-methoxy-6-methyl-2-aminoindan (IC50)amphetamine (IC50)
Phenylethanolamine N-methyltransferaseBos taurus (cattle)0.96
Cytochrome P450 2A6Homo sapiens (human)3.5
Cytochrome P450 2A5Mus musculus (house mouse)2.85
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.96
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)0.96

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnson, MP; Nichols, DE1
Marona-Lewicka, D; Nichols, DE1
Huang, X; Nichols, DE1
Marona-Lewicka, D; Nichols, DE; Thisted, RA1

Other Studies

4 other study(ies) available for 5-methoxy-6-methyl-2-aminoindan and amphetamine

ArticleYear
Combined administration of a non-neurotoxic 3,4-methylenedioxymethamphetamine analogue with amphetamine produces serotonin neurotoxicity in rats.
    Neuropharmacology, 1991, Volume: 30, Issue:7

    Topics: Amphetamine; Animals; Brain; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Hydroxyindoleacetic Acid; Indans; Male; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists

1991
Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
    European journal of pharmacology, 1994, Jun-02, Volume: 258, Issue:1-2

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Discrimination Learning; Dose-Response Relationship, Drug; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Stereoisomerism

1994
5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.
    European journal of pharmacology, 1993, Jul-20, Volume: 238, Issue:2-3

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hippocampus; Hydrazines; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists

1993
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
    Psychopharmacology, 2005, Volume: 180, Issue:3

    Topics: Amphetamine; Amphetamines; Animals; Apomorphine; Behavior, Animal; Cues; Discrimination Learning; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Haloperidol; Indans; Injections, Intraperitoneal; Lysergic Acid Diethylamide; Male; Piperidines; Psychotic Disorders; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors

2005